beMi® Programs for people prescribed REPLAGAL®

beMi Programs, developed by Takeda, provides support for patients who have been prescribed REPLAGAL (agalsidase alfa ghu).

The program offers the provision of nursing services including pathology and REPLAGAL infusions at a patient’s home or other approved location within Australia.

The program is available for patients prescribed REPLAGAL who have been stabilised in a controlled hospital setting and are tolerating their infusions well.

Patients can access program information via the beMi website at www.bemi.health. After registering, they will need to enter the access code BPREPL0807 when prompted.

Watch how beMi Programs can help with patient management
PLAY VIDEO



What services are available?

IV infusions

Infusion service performed by trained nurses with experience administering infusions in the home environment.

beMi Replagal Pathology test

Pathology service: Trained nurses will collect blood samples and deliver to the nominated pathology provider for assessment.

Resources

Patient program guide
Information about beMi Programs, including the services available and what to expect.
Patient enrolment form
Prescribers can enrol eligible patients by completing this form.

PBS Information: REPLAGAL is not listed on the PBS. REPLAGAL is funded through the Life Saving Drugs Program.

Please refer to the full approved Product information available here before prescribing.

You are now leaving the TakedaPro website

This link opens a website that is not operated by Takeda. We are not responsible for the content or availability of linked websites.

Cancel

Continue